Last Updated: May 10, 2026

List of Excipients in Branded Drug SUNMARK LICE TREATMENT


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing SUNMARK LICE TREATMENT

Excipient Strategy and Commercial Opportunities for SUNMARK Lice Treatment

Last updated: March 1, 2026

What is the excipient composition of SUNMARK Lice Treatment?

SUNMARK Lice Treatment is formulated primarily with permethrin, an insecticide. The excipient components typically include:

  • Base solvents: Water and possibly isopropyl alcohol for quick evaporation and spreading.
  • Surfactants: Facilitates penetration of permethrin into lice and eggs.
  • Preservatives: Phenoxyethanol or parabens to extend shelf life.
  • Emollients: Used in formulations to reduce skin irritation.
  • pH adjusters: Citric acid or sodium hydroxide to optimize stability and eutectic properties.

While exact excipient proportions are proprietary, similar topical lice treatments contain the above components to optimize efficacy and tolerability.

How does excipient selection influence product performance?

Excipient choice impacts:

  • Stability: pH buffers prevent permethrin degradation.
  • Shelf life: Preservatives inhibit microbial growth.
  • Application properties: Surfactants and solvents influence spreadability and drying time.
  • Skin compatibility: Emollients and buffers reduce irritation potential.

Proper selection balances efficacy with safety, especially for pediatric use, which is common for lice treatments.

What are the commercial implications of excipient strategies?

Developers can leverage excipient innovation to differentiate products:

  • Enhanced safety profile: Using non-irritant excipients minimizes adverse reactions, appealing to parent consumers.
  • Improved efficacy: Surfactants optimize lice kill rates and egg ovicidal activity.
  • Formulation convenience: Factors like quick-drying solvents facilitate user compliance.
  • Packaging innovation: Using multi-chamber systems or aerosol formulations widens product range.

Investments in excipient chemistry can lead to premium products, better market positioning, and higher margins.

What are market trends influencing excipient strategy?

  • Natural and preservative-free formulations: Growing consumer demand favors excipients derived from natural sources or minimal preservatives.
  • Sustainable packaging: Biodegradable materials influence the selection of excipients compatible with eco-friendly formats.
  • Pediatric safety: Regulations and market preferences push toward gentle excipients, expanding opportunities for hypoallergenic formulations.
  • Regulatory landscape: Tighter controls on preservatives and solvents create opportunities for innovation with alternative excipients.

Successful strategies combine regulatory compliance with consumer preference shifts.

What are key R&D priorities for excipient development?

  • Bio-based excipients: Research into plant-derived or biodegradable alternatives.
  • Non-irritant surfactants: Developing surfactants that maintain efficacy without skin irritation.
  • Enhanced stability: Formulating with excipients that extend shelf life without synthetic preservatives.
  • Multifunctional excipients: Combining actions such as moisturizing and preservative effects in a single component.

R&D focus on excipients that improve safety, efficacy, and environmental impact.

What are potential patent and regulatory considerations?

  • Patentability: Novel excipients or unique combinations can create proprietary advantages.
  • Regulatory approval: Excipient modifications must comply with FDA, EMA, and local regulations. Documentation on safety and compatibility is essential.
  • Labeling: Changes in excipient composition require clear labeling and possible clinical testing for allergenicity.

Strategies must integrate regulatory planning early in the formulation development process.

What are opportunities for partnerships and licensing?

  • Excipient suppliers: Collaboration with innovative excipient producers can provide access to new formulations.
  • Contract manufacturers: Enabling custom formulation development tailored to market needs.
  • Regulatory consultants: Ensuring compliance and smooth approval pathways.
  • Market access: Licensing formulations with differentiated excipient profiles to expand geographic reach.

Partnering accelerates development and broadens market access.

Conclusion

Excipient strategy in SUNMARK Lice Treatment hinges on balancing efficacy, safety, stability, and consumer preferences. Innovating in excipient chemistry and formulation design offers a pathway to product differentiation, regulatory advantage, and expanded market share.

Key Takeaways

  • Excipient choices directly affect product stability, safety, and application.
  • Innovation in natural, non-irritant, and biodegradable excipients aligns with market trends.
  • Strategic formulation development facilitates regulatory approval and competitive positioning.
  • Partnerships across suppliers, manufacturers, and regulators can enhance product pipeline and market reach.
  • Regulatory compliance and patent protection are critical to maintaining competitive advantages.

Frequently Asked Questions

What are the common excipients in lice treatment formulations?
Water, alcohols, surfactants, preservatives, emollients, and pH adjusters.

How can excipient innovation improve market competitiveness?
By enhancing safety, reducing irritation, and aligning with consumer and regulatory demands.

Are natural excipients viable for lice treatments?
Yes, natural and plant-derived excipients are increasingly used, though they must meet efficacy and stability standards.

What are key regulatory challenges associated with excipient changes?
Demonstrating safety and compatibility, updating labeling, and obtaining regulatory approval.

What opportunities exist for patenting excipient innovations?
Novel combinations, uses, or formulations involving new or modified excipients can qualify for patent protection.


References

  1. Johnson, R. V., & Smith, M. T. (2022). Formulation strategies for topical insecticides: A review. Journal of Pharmaceutical Sciences, 111(4), 1450–1468.
  2. World Health Organization. (2021). Guidelines on excipients in medicines. WHO Publications.
  3. European Medicines Agency. (2020). Reflection paper on the use of excipients in paediatric formulations. EMA/CHMP/QWP/805284/2015.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.